약학회지

ISSN 0377-9556 (PRINT)
ISSN 2383-9457 (ONLINE)

Fig. 2.

Download original image
Fig. 2. The mechanism of action of maralixibat. Inhibition of ASBT results in increased fecal bile acid excretion, leading to decreased levels of bile acids systemically and thereby reducing bile acid mediated liver damage. This leads to improvements in liver function, pruritus and other symptoms of cholestetic liver diseases.62)
Yakhak Hoeji 2022;66:115-24 https://doi.org/10.17480/psk.2022.66.3.115
© 2022 Yakhak Hoeji